434 Fayetteville St.,Suite 500
Raleigh , NC, 27601

Rank

Rank Universe

Summary

The fund seeks capital appreciation in the long term by investing in companies across any size in the United States.

The investment process focuses on companies in the benchmark index that are lagging in market price due to temporary economic circumstances and trading at a discount to their estimated intrinsic value.

The investment team also integrates environmental, social, and governance factors into its investment proces More

Link

Directors

Dec 11, 2023
  • Douglas R. Van Scoy
  • Alan G. Priest
  • Laura C. Bingham
  • Drew T. Kagan
  • David L. Wedding
  • Scott A. Haenni
  • Kimberly R. Storms

Chief Compliance Officer

  • Charles A. Durham

Fund Manager(s)

  • Joshua Haggerty
  • Daniel Morrall

Price

  • $ 25.12 ( -0.12 )
    Jan 31, 2025
    Last Close
  • Net Assets
  • $440.9M
    Feb 23, 2024
  • Holding
  • 32
    Aug 21, 2024
    More

  • 52-Week High/Low
  • $30.62 - $24.1
  • Turnover
  • 33%
  • Expense Ratio
  • 1.16%

Company Name

Holding

Teva Pharmaceutical Industries 5.32 %
Amazon.com Inc 5.28 %
Marvell Technology Inc 5.14 %
Alphabet Inc 4.67 %
Microsoft Corp 4.59 %
UnitedHealth Group Inc 4.4 %
Charles Schwab Corp/The 4.37 %
Coherent Corp 4.32 %
Oracle Corp 3.92 %
Global Payments Inc 3.87 %
More 3.87 %

Documents

Prospectus

Annual Reports

Performance

YTD

-

3 Year

-16.88%

5 Year

0.16%

Best

38.21%

2009

Worst

-32.41%

2008

Alpha

BOPAX Russell 3000 Index

Chart +